Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Med Case Rep ; 17(1): 441, 2023 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-37872576

RESUMO

BACKGROUND: Dacryoadenitis is inflammation of the lacrimal gland, mainly caused by viral infection. It can also be caused by bacterial pathogens and non-infectious processes such as auto-immune diseases and malignancy. Chronic dacryoadenitis is rarely linked to SARS-CoV-2 infection, with only five reports in the literature. REPORT: A 26-year-old Arab woman experienced chronic inflammatory dacryoadenitis after a mild SARS-CoV-2 infection, which was successfully treated with oral prednisone. CONCLUSIONS: Dacryoadenitis can occur due to inflammation caused by either SARS-CoV-2 exposure. The treatment typically involves the administration of steroids, with duration to be decided based on clinical response.


Assuntos
COVID-19 , Dacriocistite , Aparelho Lacrimal , Feminino , Humanos , Adulto , COVID-19/complicações , COVID-19/patologia , SARS-CoV-2 , Dacriocistite/diagnóstico , Dacriocistite/tratamento farmacológico , Dacriocistite/etiologia , Aparelho Lacrimal/patologia , Inflamação
3.
Oxf Med Case Reports ; 2023(1): omac146, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36694598

RESUMO

Clostridium cadaveris (C. cadaveris), a strict anaerobic gram-positive rod, is rarely reported in clinical specimens. Since its detection in 1899, it has always been linked to the decay of dead bodies. C. cadaveris is considered non-pathogenic to humans, however infrequently it can cause severe infections including bacteremia. The latter was typically associated with gastro-intestinal pathologies. We report the first case of C. cadaveris invasive infection at Sultanate Oman. The source was most probably an infected decubitus ulcer.

6.
J Infect Public Health ; 14(9): 1233-1236, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34454173

RESUMO

Campylobacter fetus is a rare pathogen in humans. It mainly causes invasive infections in immunosuppressed patients. Herein, we report the first case of cervical vertebral osteomyelitis in a previously healthy man with a history of daily alcohol consumption. Treatment was given for six weeks with excellent clinical recovery and normalization of laboratory markers.


Assuntos
Infecções por Campylobacter , Osteomielite , Infecções por Campylobacter/diagnóstico , Infecções por Campylobacter/tratamento farmacológico , Campylobacter fetus , Humanos , Masculino , Osteomielite/diagnóstico , Osteomielite/tratamento farmacológico
7.
J Mycol Med ; 31(3): 101168, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34186378

RESUMO

INTRODUCTION: Critically ill COVID-19 patients are at high risk for nosocomial bacterial and fungal infections due to several predisposing factors such as intensive care unit stay, mechanical ventilation, and broad-spectrum antibiotics. Data regarding multidrug resistant (MDR) Candida species in COVID-19 patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections. CASE DESCRIPTION: A 34-year-old male presented to our institution with acute respiratory distress syndrome (ARDS) due to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics and prolonged mechanical ventilation. He died after recurrent pneumothorax led to respiratory failure and cardiac arrest. DISCUSSION: Bacterial and fungal infections are common complications of viral pneumonia in critically ill patients. Data regarding these infections in COVID-19 patients has been poorly studied with only a few cases reporting secondary infection, mostly without identifying specific pathogens. Prolonged hospital stays, invasive interventions (central venous catheter, mechanical ventilation), and the use of broad-spectrum antibiotics in COVID-19 infections could carry a high risk of bacterial and/or fungal superinfections. CONCLUSION: Strategies to improve outcome in COVID-19 ICU patients should include early recognition of candidemia and appropriate antifungal therapy.


Assuntos
COVID-19/complicações , Candidemia/tratamento farmacológico , Superinfecção/tratamento farmacológico , Adulto , Antifúngicos/uso terapêutico , Candida , Candidemia/complicações , Evolução Fatal , Humanos , Masculino , Respiração Artificial , Síndrome do Desconforto Respiratório , Saccharomycetales , Superinfecção/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA